Neratinib: clinical trial data in HER2-positive metastatic breast cancer

Clin Adv Hematol Oncol. 2020 Sep;18 Suppl 15(9):7-11.NO ABSTRACTPMID:33843840

Source: Clinical Breast Cancer - April 12, 2021 Category: Cancer & Oncology Authors: Joyce A O'Shaughnessy Source Type: research